Relafen Drug Interactions
Currently displaying 95 drugs known to have a major interaction with Relafen (nabumetone).
- 95 major drug interactions
- 261 moderate drug interactions
- 8 minor drug interactions
Major interactions with Relafen (nabumetone)
Note: Showing generic names only.
A
B
C
D
- dabigatran
- dalteparin
- danaparoid
- dasatinib
- deferasirox
- desirudin
- diatrizoate
- diclofenac
- dicumarol
- diflunisal
- drotrecogin alfa
E
F
I
- ibritumomab
- ibrutinib
- ibuprofen
- immune globulin intravenous
- immune globulin intravenous and subcutaneous
- indomethacin
- inotersen
- iodamide
- iodine i 131 tositumomab
- iodipamide
- iodixanol
- iohexol
- iomeprol
- iopamidol
- iopromide
- iothalamate
- ioversol
- ioxaglate
- ioxilan
K
L
M
N
O
P
- panobinostat
- peanut allergen powder
- pexidartinib
- phenylbutazone
- piroxicam
- plasminogen, human
- ponatinib
- prasugrel
R
- ramucirumab
- regorafenib
- respiratory syncytial virus immune globulin
- rho (d) immune globulin
- rivaroxaban
- rofecoxib
S
T
- tacrolimus
- temsirolimus
- tenofovir alafenamide
- tenofovir disoproxil
- teriflunomide
- tinzaparin
- tolmetin
- tositumomab
- tovorafenib
V
W
Z
Relafen alcohol/food interactions
There are 3 alcohol/food interactions with Relafen (nabumetone).
Relafen disease interactions
There are 13 disease interactions with Relafen (nabumetone) which include:
- asthma
- fluid retention
- GI toxicity
- rash
- renal toxicities
- thrombosis
- liver disease
- anemia
- heart failure
- hepatotoxicity
- hyperkalemia
- hypertension
- platelet aggregation inhibition
More about Relafen (nabumetone)
- Relafen consumer information
- Check interactions
- Compare alternatives
- Reviews (38)
- Drug images
- Latest FDA alerts (4)
- Side effects
- Dosage information
- During pregnancy
- Drug class: Nonsteroidal anti-inflammatory drugs
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.